A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis

Completed · Phase 3

Conditions studied: End Stage Renal Disease, Kidney Failure, Renal Failure, Hyperphosphatemia, ESRD

In brief

A long-term safety study of ferric citrate (KRX-0502) in renal failure patients who have completed study KRX-0502-304. Only patients who participated in the KRX-0502-304 trial may participate in this trial.

Key facts

Study ID
NCT01554982
Run by
Keryx Biopharmaceuticals
People needed
168
Starts
2012-08-01
Expected to finish
2014-08-01
Last updated by the study team
2016-07-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.